NCT04836351

Brief Summary

A large proportion of persons who have had COVID-19 have reported persisted symptoms as fatigue and dyspnea months post infection which affect activities of daily living. The aim of the study is to examine the feasibility and safety of a concentrated rehabilitation program with a mobile application follow-up for persons with persistent symptoms post COVID-19 infection. We will examine recruitment availability, adherence to the program, goal achievement, and resources requirements. Methods: A feasibility study with one group pre-post test design with 10-20 persons between 18-67 years, with persistent symptoms post COVID-19 will be included. The intervention is 3+ 1-2 days concentrated rehabilitation with a mobile application follow-up for 3 months. Following assessments wil be used: Cardiopulmonary exercise testing, lung function, functional performance tests, questionnaires regarding dyspnea, fatigue, anxiety, depression, work-status, health status, sleep behavior, physical activity level. Demographic data before and after the intervention will be presented. Focus group interview will be done with the participants. The interview will be analysed using systematic text condensation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable covid19

Timeline
Completed

Started Mar 2021

Longer than P75 for not_applicable covid19

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2021

Completed
28 days until next milestone

First Submitted

Initial submission to the registry

March 29, 2021

Completed
10 days until next milestone

First Posted

Study publicly available on registry

April 8, 2021

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2023

Completed
Last Updated

April 8, 2021

Status Verified

April 1, 2021

Enrollment Period

2.8 years

First QC Date

March 29, 2021

Last Update Submit

April 6, 2021

Conditions

Keywords

long COVIDpost-acute COVID syndromepersistent symptoms post COVID-19

Outcome Measures

Primary Outcomes (2)

  • Cardiopulmonary exercise test (CPET)

    CPET performed at treadmill

    4 months

  • Chalder Fatigue Questionnaire (CFQ)

    Assessing fatigue

    4 months

Secondary Outcomes (13)

  • International Physical Activity Questionnaire (IPAQ)

    4 months

  • Generalized Anxiety Disorder (GAD-7)

    4 months

  • Patient Health Questionnaire (PHQ-9)

    4 months

  • Bergen Insomnia Scale (BIS)

    4 months

  • Client Satisfaction Questionnaire (CSQ-8)

    3 months

  • +8 more secondary outcomes

Study Arms (1)

Concentrated rehabilitation

EXPERIMENTAL

3+ 1-2 day concentrated rehabilitation for patients with persistent symptoms post COVID-19.

Other: Concentrated rehabilitation for patients with persistent symptoms post COVID-19

Interventions

3+ 1-2 days concentrated rehabilitation for patients with persistent symptoms post COVID-19 with a mobile application follow-up and physical consultations at 3 months post intervention.

Concentrated rehabilitation

Eligibility Criteria

Age18 Years - 67 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • persistent symptoms minimum 2 months post COVID-19 infection
  • reduced exercise capacity level
  • symptoms of dyspnea and/or fatigue

You may not qualify if:

  • diseases where exercise is contraindicated (e.g. unstable angina pectoris)
  • drug abuse, severe mental illness where treatment in groups are contraindicated.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Helse i Hardanger

Øystese, Kvam Herad, 5610, Norway

RECRUITING

MeSH Terms

Conditions

COVID-19Post-Acute COVID-19 Syndrome

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesPost-Infectious DisordersChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Gerd Kvale, PhD

    University of Bergen

    STUDY CHAIR

Central Study Contacts

Bente Frisk, PhD

CONTACT

Kiri L Njøten, MSc

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Feasibility study, one group pre-post design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ph.d student

Study Record Dates

First Submitted

March 29, 2021

First Posted

April 8, 2021

Study Start

March 1, 2021

Primary Completion

December 30, 2023

Study Completion

December 30, 2023

Last Updated

April 8, 2021

Record last verified: 2021-04

Data Sharing

IPD Sharing
Will not share

In accordance with the approvals granted for this study by The Regional Committee on Medical Research Ethics and The Norwegian Data Inspectorate, the data files are stored securely and in accordance with the Norwegian Law of Privacy Protection. A subset of the data file with anonymized data can be made available to interested researchers upon reasonable request to Bente Frisk providing Norwegian privacy legislation and General Data Protection Regulation (GDPR) are respected, and that permission is granted from The Norwegian Data Inspectorate and the data protection officer Western Norway University og Applied Sciences

Locations